[ad_1]
“Following new reports of cerebrovascular thrombosis associated with vaccination in Germany and Europe, PEI [Paulio Erhlicho institutas] believes that more research is needed, ”the Health Ministry said, citing the country’s authority responsible for surveillance of vaccination.
“The European Medicines Agency (EMA) will decide whether and how the new findings will affect the approval of this vaccine,” the ministry added.
Several European countries, including Ireland and the Netherlands, have also frozen the use of AstraZeneca, a drug developed in collaboration with the University of Oxford.
The UK and Sweden-based company and Oxford University said there was no link between the vaccine and increased blood clotting.
AstraZeneca reported that 15 cases of deep vein thrombosis (DVT) and 22 cases of pulmonary embolism were reported in vaccinated people. According to the company, this figure is “much lower than would be expected under natural conditions in the general population” in terms of total injections.
The vaccine is widely used for vaccination in Britain, but the European Union has experienced an interruption in the supply of AstraZeneca.
Italy and France are also stopping vaccines
Italy and France said Monday they were following the lead of other European countries and stopping vaccines against the coronavirus vaccine, developed by AstraZeneca and the University of Oxford, following fears that the drug could stimulate blood clots.
A report from the Italian Medicines Agency states: “” AIFA has decided to extend the ban on the use of AstraZeneca COVID-19 as a preventive and temporary measure pending the decisions of the European Medicines Agency (EMA). “
It also claims that this decision is in line with similar steps in other European countries.
French President Emmanuel Macron has also announced that vaccination with AstraZeneca is being stopped in his country and that EVA conclusions are awaited.
“A decision has been made … to suspend the use of AstraZeneca as a precaution, in the hope that we can resume it soon if the EVA evaluation allows it,” Macron told a press conference. He added that an EVA decision is expected on Tuesday afternoon.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
